Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Human signal transducer and activator of transcription 3 (STAT3) is one of many genes containing a tandem splicing site. Alternative donor splice sites 3 nucleotides apart result in either the inclusion (S) or exclusion (ΔS) of a single residue, Serine-701. Further downstream, splicing at a pair of alternative acceptor splice sites result in transcripts encoding either the 55 terminal residues of the transactivation domain (α) or a truncated transactivation domain with 7 unique residues (β). As outlined in this manuscript, measuring the proportions of STAT3's four spliced transcripts (Sα, Sβ, ΔSα and ΔSβ) was possible using absolute qPCR (quantitative polymerase chain reaction). The protocol therefore distinguishes and measures highly similar splice variants. Absolute qPCR makes use of calibrator plasmids and thus specificity of detection is not compromised for the sake of efficiency. The protocol necessitates primer validation and optimization of cycling parameters. A combination of absolute qPCR and efficiency-dependent relative qPCR of total STAT3 transcripts allowed a description of the fluctuations of STAT3 splice variants' levels in eosinophils treated with cytokines. The protocol also provided evidence of a co-splicing interdependence between the two STAT3 splicing events. The strategy based on a combination of the two qPCR techniques should be readily adaptable to investigation of co-splicing at other tandem splicing sites.

[1]  J. DiGiovanni,et al.  Non‐canonical Stat3 signaling in cancer , 2016, Molecular carcinogenesis.

[2]  R. Aebersold,et al.  On the Dependency of Cellular Protein Levels on mRNA Abundance , 2016, Cell.

[3]  D. Tweardy,et al.  A mix of S and ΔS variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture , 2016, Oncogenesis.

[4]  T. Blauwkamp,et al.  Comprehensive transcriptome analysis using synthetic long-read sequencing reveals molecular co-association of distant splicing events , 2015, Nature Biotechnology.

[5]  L. Rui,et al.  Ratios of Four STAT3 Splice Variants in Human Eosinophils and Diffuse Large B Cell Lymphoma Cells , 2015, PloS one.

[6]  K. Szafranski,et al.  It's a bit over, is that ok? The subtle surplus from tandem alternative splicing , 2015, RNA biology.

[7]  M. Wang,et al.  Alternative splicing at GYNNGY 5′ splice sites: more noise, less regulation , 2014, Nucleic acids research.

[8]  D. Bates,et al.  Hallmarks of alternative splicing in cancer , 2014, Oncogene.

[9]  K. Huse,et al.  Physiological state co-regulates thousands of mammalian mRNA splicing events at tandem splice sites and alternative exons , 2014, Nucleic acids research.

[10]  R. Lai,et al.  STAT3 in Cancer—Friend or Foe? , 2014, Cancers.

[11]  S. Thunberg,et al.  Novel STAT3 Mutation Causing Hyper-IgE Syndrome: Studies of the Clinical Course and Immunopathology , 2014, Journal of Clinical Immunology.

[12]  B. Rini,et al.  Signal Integration and Gene Induction by a Functionally Distinct STAT3 Phosphoform , 2014, Molecular and Cellular Biology.

[13]  Lin Ying Liu,et al.  Potent synergistic effect of IL-3 and TNF on matrix metalloproteinase 9 generation by human eosinophils. , 2012, Cytokine.

[14]  Christopher B. Burge,et al.  Alternative Splicing of RNA Triplets Is Often Regulated and Accelerates Proteome Evolution , 2012, PLoS biology.

[15]  L. Cartegni,et al.  Antitumorigenic potential of STAT3 alternative splicing modulation , 2011, Proceedings of the National Academy of Sciences.

[16]  Martin G. Ensenberger,et al.  Extended Binding Site on Fibronectin for the Functional Upstream Domain of Protein F1 of Streptococcus pyogenes* , 2010, The Journal of Biological Chemistry.

[17]  Anil K. Malhotra,et al.  Novel multi-nucleotide polymorphisms in the human genome characterized by whole genome and exome sequencing , 2010, Nucleic acids research.

[18]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[19]  Michael Hiller,et al.  Widespread and subtle: alternative splicing at short-distance tandem sites. , 2008, Trends in genetics : TIG.

[20]  Rolf Backofen,et al.  Alternative splicing at NAGNAG acceptors in Arabidopsis thaliana SR and SR-related protein-coding genes , 2008, BMC Genomics.

[21]  Bodo Grimbacher,et al.  STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.

[22]  K. Tsai,et al.  Quantitative analysis of wobble splicing indicates that it is not tissue specific. , 2006, Genomics.

[23]  Rolf Backofen,et al.  Phylogenetically widespread alternative splicing at unusual GYNGYN donors , 2006, Genome Biology.

[24]  A. Eke,et al.  The modified Beer–Lambert law revisited , 2006, Physics in medicine and biology.

[25]  Christina L. Zheng,et al.  Characteristics and regulatory elements defining constitutive splicing and different modes of alternative splicing in human and mouse. , 2005, RNA.

[26]  Toshiyuki Miyashita,et al.  Frequent occurrence of protein isoforms with or without a single amino acid residue by subtle alternative splicing: the case of Gln in DRPLA affects subcellular localization of the products , 2005, Journal of Human Genetics.

[27]  Rolf Backofen,et al.  Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.

[28]  Stephen A. Bustin,et al.  A-Z of Quantitative PCR , 2004 .

[29]  M. Whelan,et al.  A method for the absolute quantification of cDNA using real-time PCR. , 2003, Journal of immunological methods.

[30]  E. Papoutsakis,et al.  Differential expression and phosphorylation of distinct STAT3 proteins during granulocytic differentiation. , 2002, Blood.

[31]  Daniel Nathans,et al.  Specific Ablation of Stat3β Distorts the Pattern of Stat3-Responsive Gene Expression and Impairs Recovery from Endotoxic Shock , 2002, Cell.

[32]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[33]  J. Miyazaki,et al.  Tissue-Specific Autoregulation of thestat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells , 2001, Molecular and Cellular Biology.

[34]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[35]  J. Lammers,et al.  STAT3β, a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of Transcription* , 1996, The Journal of Biological Chemistry.

[36]  L. Sanders,et al.  Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Darnell,et al.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors , 1995, Science.

[38]  E. Turner,et al.  Twin of I-POU: A two amino acid difference in the I-POU homeodomain distinguishes an activator from an inhibitor of transcription , 1992, Cell.

[39]  D. Hanahan,et al.  Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Boultwood,et al.  The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes. , 2014, Advances in Biological Regulation.

[41]  S. Dewilde,et al.  The STAT3 isoforms alpha and beta have unique and specific functions. , 2004, Nature immunology.

[42]  Frank Vitzthum,et al.  Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. , 2004, Nucleic acids research.

[43]  H. Too.  Real time PCR quantification of GFRalpha-2 alternatively spliced isoforms in murine brain and peripheral tissues. , 2003, Brain research. Molecular brain research.